Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancer
Not Applicable
Recruiting
- Conditions
- non-metastatic prostate cancer
- Registration Number
- JPRN-UMIN000040914
- Lead Sponsor
- Department of Urology, Gunma University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1 Epileptic state patients 2 Brain damage, apoplexy, brain metastatis, active epidural metastatis of cranium 3 Hypersensitivity to darolutamide or its component 4 Severe liver dysfunction 5 Severe kidney function 6 Cases with distant metastases at the first visit 7 Impropriate state judged by charged doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method